We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2282:HKEXMGM China Holdings Limited Analysis

Data as of 2026-08-10 - not real-time

HK$10.28

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

MGM China Holdings Limited trades at HKD 10.28, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 3.7%. With RSI at 42.5 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at HKD 9.94 up to resistance at HKD 11.45.
Multiples put this in fair territory at a P/E of 7.7. Sell-side targets cluster 42.0% above the current quote. Revenue is growing at 4.4% on a 12.9% profit margin. The 5.90% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 38.9%, a beta of 0.25 and a maximum drawdown of 42.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top Market Events

Updated Jun 18, 2026 0 - Important addition to China-related risk management tools offered by HKEX - Supporting growth...Hong Kong Exchanges and Clearing Limited HKEX welcomes the announcement today Thursday by the Securities and Futures...Important addition to China-related risk management tools offered by HKEX Supporting growth of Hong Kong's RMB product...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 12.57
  • MACD momentum is negative
  • Maximum drawdown of 42.0%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 12.57
  • Analyst targets imply +42.0% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +42.0% versus the current price
  • P/E ratio of 7.7
  • Return on equity of 158.7%

Key Metrics & Analysis

Financial Health

Revenue Growth4.40%
Profit Margin12.93%
P/E Ratio7.7
ROE158.68%
ROA12.76%
Debt/Equity475.85
P/B Ratio12.0
Op. Cash FlowHK$7.9B
Free Cash FlowHK$3.8B

Technical Analysis

TrendNeutral
RSI42.5
SupportHK$9.94
ResistanceHK$11.45
MA 20HK$10.66
MA 50HK$10.56
MA 200HK$12.57
MACDBearish
VolumeIncreasing
Fear & Greed Index93.88

Valuation

Fair ValueHK$11.67
Target PriceHK$14.59
Upside/Downside41.96%
GradeFair
TypeBlend
Dividend Yield5.90%

Risk Assessment

Beta0.25
Volatility38.90%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.